Skip to main content
. 2022 Jan 1;17(4):1013–1021. doi: 10.1007/s11739-021-02891-w

Table 6.

Multivariate analysis for death in patients aged ≥ 59 years

OR (95% CI)
Age 1.1 (1.1–1.1)
Thromboprophylactic treatment (all dosages) 0.4 (0.3–0.6)
Peripheral Obstructive Arterial Disease 4.9 (1.6–15.1)
Neurological disease 1.6 (1.0–2.5)